《大行報告》大和升網易(09999.HK)目標價至220元 即將推出遊戲為短期催化劑
大和發表報告指,網易-S(09999.HK)去年第四季網上遊戲收入及盈利,較市場預期分別低5%及7%,不過季度股息高於該行預期,相信未來將會推出的新遊戲,例如3月底的《射鵰英雄傳》及第二季度的《燕雲十六聲》,將會成為股價的短期催化劑,維持其「買入」評級,目標價由215元上調至220元。
報告指,網易上季網上遊戲毛利率69.5%,按年升10.4個百分點,主要受惠自家遊戲及非Android分銷渠道的收入貢獻提升,基於其遊戲產品線強勁,已推出遊戲的收入亦穩定,仍然看好網易的盈利前景。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.